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background:  Clinical uncertainty remains regarding the value of coronary reperfusion and revascularization strategies (RRS) among older 
patients admitted with acute myocardial infarction (AMI) with cardiogenic shock (CS). This study assesses the impact of RRS on mortality 
by age group among AMI patients presenting with CS.
methods:  This retrospective analysis uses the MedPAR data files for fiscal years 2011 and 2012. The sample consists of 48,816 Medicare 
beneficiaries (MBs) hospitalized with an AMI (STEMI or NSTEMI) in whom CS was present on admission. Outcomes included: in-hospital, 
30- and 90-day mortality rates. Logistic regression analysis, estimated separately for MBs under age 80 and 80 plus, was used to 
determine if RRS reduces the likelihood (odds ratios < 1.0) of dying relative to MBs receiving no RRS, after controlling for gender, race, and 
41 co-morbid conditions.
Results:  The first row of the table reports observed mortality rates among MB receiving no RRS. The estimated odds ratios finds that, 
except for thrombolytics only, all RRS significantly reduces (p<0.01) the likelihood of in hospital and intermediate mortality in both age 
groups compared to MBs not receiving any RRS. Further, the magnitude of the estimated odds by RRS is very similar in size between the 
two age groups for each mortality measure.
conclusion:  As employed by practicing physicians, advanced age should not preclude clinically appropriate reperfusion or 
revascularization in AMI patients presenting with CS.
 
